What question did this study set out to answer?

This research identifies the antitumor effects of the arylpiperazine derivative NAF19 on prostate cancer cells.

April 5, 2026Open Access

Arylpiperazine Derivative NAF19 Inhibits Prostate Cancer Activity and Its Molecular Mechanisms

Key Points

This research identifies the antitumor effects of the arylpiperazine derivative NAF19 on prostate cancer cells.
Investigated the effects of NAF19 on prostate cancer cell lines
Analyzed AR/AR-Vs signaling pathways
Assessed apoptotic cascades
Evaluated cellular migratory, invasive, and proliferative capacities
NAF19 significantly inhibited AR/AR-Vs signaling pathways
Activated apoptotic cascades leading to increased cancer cell death
Suppressed migratory and invasive abilities of prostate cancer cells
Reduced overall proliferation of prostate cancer cells

Abstract

The novel arylpiperazine derivative NAF19 exerts multi-targeted antitumor effects by concurrently inhibiting AR/AR-Vs signaling pathways and activating apoptotic cascades, thereby potently suppressing the migratory, invasive, and proliferative capacities of prostate cancer cells.

AIに質問

Bookmark

View Full Paper